(30 days)
No
The document explicitly states "Mentions AI, DNN, or ML: Not Found" and does not describe any AI/ML-specific training or test sets.
No
The device is described as a "diagnostic aid for the detection of sleep related breathing disorders" and an "aid to the physician ... if further arrhythmia investigation is needed," explicitly stating it is "not intended to be used as a diagnostic device for cardiac arrhythmia." It does not provide any treatment or therapy.
Yes
The 'Intended Use / Indications for Use' section explicitly states, "The WP1 is a diagnostic aid for the detection of sleep related breathing disorders..." and mentions the generation of indices like PRDI and PAHI, which are used in diagnosing sleep disorders.
No
The device description explicitly lists hardware components including a wrist worn Control Unit, Actigraphy (in the Control Unit), Wrist Strap, Power Supply (battery), uPAT probe, and optional Chest sensor, in addition to the software.
Based on the provided text, the WatchPAT ONE (WP1) device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs analyze specimens taken from the human body. The description of the WatchPAT ONE focuses on non-invasive measurements taken from the wrist, finger, and chest (optional). It measures physiological signals like peripheral arterial tonometry (PAT), actigraphy, snoring level, and body position. These are not biological specimens like blood, urine, or tissue that are typically analyzed by IVDs.
- The intended use is for diagnosing sleep-related breathing disorders. While this is a diagnostic aid, it's based on physiological measurements, not the analysis of in vitro samples.
- The device description and performance studies focus on signal acquisition and analysis algorithms. The testing described involves bench testing to show equivalence of signals and software design verification. This aligns with devices that measure physiological parameters rather than analyze biological samples.
Therefore, the WatchPAT ONE falls under the category of a non-invasive diagnostic device for sleep-related breathing disorders, not an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
The WatchPAT ONE (WP1) device is a noninvasive home care device for use with patients suspected to have sleep related breathing disorders. The WP1 is a diagnostic aid for the detection of sleep related breathing disorders, sleep staging (Rapid Eye Movement (REM) Sleep, Light Sleep, Deep Sleep and Wake), snoring level and body position. The WP1 generates a peripheral arterial tonometry ("PAT") Respiratory Disturbance Index ("PRDI"), Apnea- Hypopnea index ("PAHI"), Central Apnea-Hypopnea index ("PAHIc"), PAT sleep staging identification (PSTAGES) and optional snoring level and body position discrete states from an external integrated snoring and body position sensor. The WP1's PSTAGES and snoring level and body position provide supplemental information to its PRD/PAHI/PAHIc. The WP1's PSTAGES and snoring level and body position are not intended to be used as the sole or primary basis for diagnosing any sleep related breathing disorder, prescribing treatment, or determining whether additional diagnostic assessment is warranted.
PAHIc is indicated for use in patients 17 years and older. All other parameters are indicated for 12 years and older.
Product codes (comma separated list FDA assigned to the subject device)
MNR
Device Description
The subject WatchPAT ONE (WP1) has the same intended use and indications for use as the cleared predicate WP300 (K222331) and the cleared reference WP1 (K183559). The subject WP1 combines the software arrhythmia feature of the WP300 cleared predicate (K222331) into the WP1 cleared reference (K183559).
The subject WP1 consists of: A wrist worn Control Unit, Actigraphy (in the Control Unit), Wrist Strap, Power Supply (battery), uPAT probe, Chest sensor (optional), Management and Analysis Software (SW) and mobile application.
The subject WP1, like the predicate WP300 and reference WP1, uses the same Management and Analysis Software (SW). The arrhythmia feature is to be used for informational use only, to flaq patients suspected of having arrhythmias, thereby aiding the physician to decide if further arrhythmia investigation is needed. The device is not intended to be used as a diagnostic device for cardiac arrhythmia and it is not intended to replace traditional methods of diagnosis. The arrhythmia detection is not intended for use in life supporting or sustaining systems or monitor and alarm devices. It provides the sleep physician with additional information to that of the WP1 cleared capabilities of detecting sleep disorders, to be considered in conjunction with the physician's knowledge of patient background, clinical history, symptoms, and other diagnostic information.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Wrist, finger and chest (optional)
Indicated Patient Age Range
PAHIc is indicated for use in patients 17 years and older. All other parameters are indicated for 12 years and older.
Intended User / Care Setting
Home Use Physician
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
SW Design verification was performed on the subject WP1 device with the SW containing the additional arrhythmia feature. The testing and acceptance criteria are the same as those in the predicate WP300 and reference WP1 devices. Bench testing was previously conducted on the reference WP1 (K183559) to show that the acquisition system of the WP1 and WP300 generate equivalent input signals to the analysis algorithms. Specifically, the equivalence of the PAT and the actigraphy signals which are used in the newly added arrhythmia algorithm were tested. This testing provides evidence that the WP1 signals are equivalent to the WP300 signals.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 868.2375 Breathing frequency monitor.
(a)
Identification. A breathing (ventilatory) frequency monitor is a device intended to measure or monitor a patient's respiratory rate. The device may provide an audible or visible alarm when the respiratory rate, averaged over time, is outside operator settable alarm limits. This device does not include the apnea monitor classified in § 868.2377.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food & Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
January 6, 2023
Itamar Medical, LTD % Jonathan Kahan, Partner Hogan Lovells US LLP 555 Thirteenth Street. NW Washington, District of Columbia 20004-1109
Re: K223675
Trade/Device Name: WatchPAT ONE (WP1) Regulation Number: 21 CFR 868.2375 Regulation Name: Breathing Frequency Monitor Regulatory Class: Class II Product Code: MNR Dated: December 7, 2022 Received: December 7, 2022
Dear Jonathan Kahan:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
1
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Rachana Visaria -S
Rachana Visaria, Ph.D. Assistant Director DHT1C: Division of Sleep Disordered Breathing, Respiratory and Anesthesia Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K223675
Device Name WatchPAT ONE (WP1)
Indications for Use (Describe)
The WatchPAT ONE (WP1) device is a noninvasive home care device for use with patients suspected to have sleep related breathing disorders. The WP1 is a diagnostic aid for the detection of sleep related breathing disorders, sleep staging (Rapid Eye Movement (REM) Sleep, Light Sleep, Deep Sleep and Wake), snoring level and body position. The WP1 generates a peripheral arterial tonometry ("PAT") Respiratory Disturbance Index ("PRDI"), Apnea- Hypopnea index ("PAHI"), Central Apnea-Hypopnea index ("PAHIC"), PAT sleep staging identification (PSTAGES) and optional snoring level and body position discrete states from an external integrated snoring and body position sensor. The WP1's PSTAGES and snoring level and body position provide supplemental information to its PRD/PAHI/PAHIc. The WP1's PSTAGES and snoring level and body position are not intended to be used as the sole or primary basis for diagnosing any sleep related breathing disorder, prescribing treatment, or determining whether additional diagnostic assessment is warranted.
PAHIc is indicated for use in patients 17 years and older. All other parameters are indicated for 12 years and older.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ☑ Prescription Use (Part 21 CFR 801 Subpart D) | ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) SUMMARY
| Applicant's Name: | Itamar Medical Itd. |
|---|---|
| 9 Halamish st. | |
| Caesarea 3088900, Israel | |
| Tel: +972 4 617 7000 | |
| Fax: +972 4 627 5598 |
- Contact Person: Jonathan Kahan, Esq. Hogan Lovells US LLP Columbia Square 555 Thirteenth Street, NW Washington, DC 20004-1109 Tel: (202)637-5794 Fax: (202)637-5910 Email: jonathan.kahan@hoganlovells.com
- November 30th, 2022 Date Prepared:
Trade Name: WatchPAT ONE (WP1)
Common or Usual Name: Ventilatory Effort Recorder
Classification Name: Breathing Frequency Monitor
Medical Specialty: Anesthesiology
Product Code: Ventilatory Effort Recorder, MNR
Device Class: Class II
Regulation Number: 868.2375
Panel: Anesthesiology
Predicate Device: WatchPAT300 (WP300) (Itamar Medical Ltd), cleared under K222331; product code MNR
Reference Device: WatchPAT ONE (WP1) (Itamar Medical Ltd.), cleared under K183559; product code MNR
Purpose of the Special 510(k) notice.
The subject WP1 combines the software arrhythmia feature of the predicate device WP300 (K222331) into the reference device WP1 (K183559).
4
Intended Use
The WatchPAT ONE is a non-invasive home care device for use with patients suspected to have sleep related breathing disorders. The WP1 is a diagnostic aid for the detection of sleep related breathing disorders, sleep staging (Rapid Eye Movement (REM) Sleep, Light Sleep, Deep Sleep and Wake), snoring level and body position. The WP1 generates a peripheral arterial tonometry ("PAT") Respiratory Disturbance Index ("PRDI"). Apnea-Hypopnea index ("PAHI"). Central Apnea-Hypopnea index ("PAHIc"). PAT sleep staging identification (PSTAGES) and optional snoring level and body position discrete states from an external integrated snoring and body position sensor. The WP1's PSTAGES and snoring level and body position provide supplemental information to its PRDI/PAHI/PAHIc. The WP1's PSTAGES and snoring level and body position are not intended to be used as the sole or primary basis for diagnosing any sleep related breathing disorder, prescribing treatment, or determining whether additional diagnostic assessment is warranted.
PAHIc is indicated for use in patients 17 years and older. All other parameters are indicated for 12 years and older.
Device Description
The subject WatchPAT ONE (WP1) has the same intended use and indications for use as the cleared predicate WP300 (K222331) and the cleared reference WP1 (K183559). The subject WP1 combines the software arrhythmia feature of the WP300 cleared predicate (K222331) into the WP1 cleared reference (K183559).
The subject WP1 consists of: A wrist worn Control Unit, Actigraphy (in the Control Unit), Wrist Strap, Power Supply (battery), uPAT probe, Chest sensor (optional), Management and Analysis Software (SW) and mobile application.
The subject WP1, like the predicate WP300 and reference WP1, uses the same Management and Analysis Software (SW). The arrhythmia feature is to be used for informational use only, to flaq patients suspected of having arrhythmias, thereby aiding the physician to decide if further arrhythmia investigation is needed. The device is not intended to be used as a diagnostic device for cardiac arrhythmia and it is not intended to replace traditional methods of diagnosis. The arrhythmia detection is not intended for use in life supporting or sustaining systems or monitor and alarm devices. It provides the sleep physician with additional information to that of the WP1 cleared capabilities of detecting sleep disorders, to be considered in conjunction with the physician's knowledge of patient background, clinical history, symptoms, and other diagnostic information.
Technological Characteristics
The subject WP1 has the same technological characteristics as the predicate WP300 and the reference WP1 to which it has been modified.
Identically to WP300 and WP1, the subject WP1 device is a ventilatory effort recorder that utilizes Peripheral Arterial Tone (PAT) signal. It is a patient-worn device used at home for aiding in the diagnosis of sleep related breathing disorders based on the PAT signal. In all 3 systems, the controller part of the device is worn on the wrist and records the PAT signal and blood oxygen saturation levels in the distal part of the finger-mounted probe based on an optical plethysmographic method, and the wrist motion from an embedded actigraphy.
5
The following report output information is provided by the cleared WP300, cleared WP1, and the subject WP1 using the same offline SW and algorithms that analyze recorded data to present respiratory disturbance index (pRDI), Apnea Hypopnea Index (pAHI), Central Apnea Hypopnea Index (pAHIc), sleep stages (pSTAGES - REM Sleep, Light Sleep, Deep Sleep, Wake), snoring level and body position discrete states. The new arrhythmia information in the subject WP1's report is identical to the one in the cleared predicate WP300.
The subject WP1, identically to both the predicate and the reference device, consists of the same components: (1) unified PAT probe (uPAT) is used to measure the PAT and oximetry signals: (2) an embedded actigraph which provides a signal that is used to determine periods of sleep/wake based on the motion of the wrist; (3) Electronics, which include a microprocessor that records the information supplied by the uPAT finger probe, actigraph and chest movement; and (4) chest sensor (SBP/RESBP sensors same as in the predicates).
The SW characteristics of the subject WP1 and the reference WP1 are the same except for the newly added SW algorithm that was cleared for use in the predicate WP300 (K222331) to identify or 'flag' the patient for further arrhythmia investigation (Atrial Fibrillation and Premature Beats). This additional SW algorithm is the proposed modification to the subject WP1.
The HW of the subject WP1 is the same as the HW of the reference WP1 (K183559). Further, the HW of the WP1 was designed to provide identical signals to that of the predicate WP300. The differences in HW between the WP1 and the WP300 devices have been thoroughly discussed and found to be substantially equivalent in K183559.
The cleared arrhythmia SW algorithm from the predicate WP300 added to the subject WP1 does not alter the technological characteristics of the device or its principles of operation.
Performance Data
SW Design verification was performed on the subject WP1 device with the SW containing the additional arrhythmia feature. The testing and acceptance criteria are the same as those in the predicate WP300 and reference WP1 devices. Bench testing was previously conducted on the reference WP1 (K183559) to show that the acquisition system of the WP1 and WP300 generate equivalent input signals to the analysis algorithms. Specifically, the equivalence of the PAT and the actigraphy signals which are used in the newly added arrhythmia algorithm were tested. This testing provides evidence that the WP1 signals are equivalent to the WP300 signals.
Substantial Equivalence
The subject WP1 has the same intended use as both the predicate WP300 and the reference WP1. The WP1's new SW arrhythmia feature is offered as supplemental information to its sleep information. The device is not intended to be used as a diagnostic device for any cardiac arrhythmia. All other information supplied is the same as the information supplied by the predicate device and the differences in HW between the predicate WP300 (in which the new SW feature for Arrhythmia detection was cleared) and the subject WP1 do not raise new questions of safety or effectiveness.
6
| Subject WP1 | WP300 (K222331) | WP1 (K183559) | Comparison | |
|---|---|---|---|---|
| Intended Use | The WatchPAT ONE | |||
| (WP1) device is a non- | ||||
| invasive home care device | ||||
| for use with patients | ||||
| suspected to have sleep | ||||
| related breathing | ||||
| disorders. The WP1 is a | ||||
| diagnostic aid for the | ||||
| detection of sleep related | ||||
| breathing disorders, sleep | ||||
| staging (Rapid Eye | ||||
| Movement (REM) Sleep, | ||||
| Light Sleep, Deep Sleep | ||||
| and Wake), snoring level | ||||
| and body position. The | ||||
| WP1 generates a | ||||
| peripheral arterial | ||||
| tonometry ("PAT") | ||||
| Respiratory Disturbance | ||||
| Index ("PRDI"), Apnea- | ||||
| Hypopnea index ("PAHI"), | ||||
| Central Apnea-Hypopnea | ||||
| index ("PAHIc"), PAT | ||||
| sleep staging identification | ||||
| (PSTAGES) and optional | ||||
| snoring level and body | ||||
| position discrete states | ||||
| from an external integrated | ||||
| snoring and body position | ||||
| sensor. The WP1's | ||||
| PSTAGES and snoring | ||||
| level and body position | ||||
| provide supplemental | ||||
| information to its | ||||
| PRDI/PAHI/PAHIc. The | ||||
| WP1's PSTAGES and | ||||
| snoring level and body | ||||
| position are not intended | ||||
| to be used as the sole or | ||||
| primary basis for | ||||
| diagnosing any sleep | ||||
| related breathing disorder, | ||||
| prescribing treatment, or | ||||
| determining whether | ||||
| additional diagnostic | ||||
| assessment is warranted. | ||||
| PAHIc is indicated for use | ||||
| in patients 17 years and | ||||
| older. All other parameters | ||||
| are indicated for 12 years | ||||
| and older | The Watch-PAT300 | |||
| (WP300) device is a non- | ||||
| invasive home care device | ||||
| for use with patients | ||||
| suspected to have sleep | ||||
| related breathing | ||||
| disorders. The WP300 is a | ||||
| diagnostic aid for the | ||||
| detection of sleep related | ||||
| breathing disorders, sleep | ||||
| staging (Rapid Eye | ||||
| Movement (REM) Sleep, | ||||
| Light Sleep, Deep Sleep | ||||
| and Wake), snoring level | ||||
| and body position. The | ||||
| WP300 generates a | ||||
| peripheral arterial | ||||
| tonometry ("PAT") | ||||
| Respiratory Disturbance | ||||
| Index ("PRDI"), Apnea- | ||||
| Hypopnea index ("PAHI"), | ||||
| Central Apnea-Hypopnea | ||||
| index ("PAHIc"), PAT | ||||
| sleep staging identification | ||||
| (PSTAGES) and optional | ||||
| snoring level and body | ||||
| position discrete states | ||||
| from an external integrated | ||||
| snoring and body position | ||||
| sensor. The WP300's | ||||
| PSTAGES and snoring | ||||
| level and body position | ||||
| provide supplemental | ||||
| information to its | ||||
| PRDI/PAHI/PAHIc. The | ||||
| WP300's PSTAGES and | ||||
| snoring level and body | ||||
| position are not intended | ||||
| to be used as the sole or | ||||
| primary basis for | ||||
| diagnosing any sleep | ||||
| related breathing disorder, | ||||
| prescribing treatment, or | ||||
| determining whether | ||||
| additional diagnostic | ||||
| assessment is warranted. | ||||
| PAHIc is indicated for use | ||||
| in patients 17 years and | ||||
| older. All other parameters | ||||
| are indicated for 12 years | ||||
| and older | The WatchPAT ONE | |||
| (WP1) device is a non- | ||||
| invasive home care device | ||||
| for use with patients | ||||
| suspected to have sleep | ||||
| related breathing | ||||
| disorders. The WP1 is a | ||||
| diagnostic aid for the | ||||
| detection of sleep related | ||||
| breathing disorders, sleep | ||||
| staging (Rapid Eye | ||||
| Movement (REM) Sleep, | ||||
| Light Sleep, Deep Sleep | ||||
| and Wake), snoring level | ||||
| and body position. The | ||||
| WP1 generates a | ||||
| peripheral arterial | ||||
| tonometry ("PAT") | ||||
| Respiratory Disturbance | ||||
| Index ("PRDI"), Apnea- | ||||
| Hypopnea index ("PAHI"), | ||||
| Central Apnea-Hypopnea | ||||
| index ("PAHIc"), PAT | ||||
| sleep staging identification | ||||
| (PSTAGES) and snoring | ||||
| level and body position | ||||
| discrete states from an | ||||
| external integrated snoring | ||||
| and body position sensor. | ||||
| The WP1's PSTAGES and | ||||
| snoring level and body | ||||
| position provide | ||||
| supplemental information | ||||
| to its PRDI/PAHI/PAHIc. | ||||
| The WP1's PSTAGES and | ||||
| snoring level and body | ||||
| position are not intended | ||||
| to be used as the sole or | ||||
| primary basis for | ||||
| diagnosing any sleep | ||||
| related breathing disorder, | ||||
| prescribing treatment, or | ||||
| determining whether | ||||
| additional diagnostic | ||||
| assessment is warranted. | ||||
| PAHIc is indicated for use | ||||
| in patients 17 years and | ||||
| older. All other parameters | ||||
| are indicated for 12 years | ||||
| and older. | Same as WP300, | |||
| almost the same | ||||
| as WP1 reference | ||||
| device, except for | ||||
| addition of the | ||||
| word "optional", | ||||
| highlighted in | ||||
| bold . | ||||
| User Population | Adult and adolescence | |||
| (from age 12) | Adult and adolescence | |||
| (from age 12) | Adult and adolescence | |||
| (from age 12) | Same | |||
| Intended Use | ||||
| Environment | Home Use | Home Use | Home Use | Same |
| Subject WP1 | WP300 (K222331) | WP1 (K183559) | Comparison | |
| Channels | PAT, Pulse rate, Oximetry, | |||
| Actigraphy, Snoring, Body | ||||
| Position, Chest Movement | PAT, Pulse rate, Oximetry, | |||
| Actigraphy, Snoring, Body | ||||
| Position, Chest Movement | PAT, Pulse rate, Oximetry, | |||
| Actigraphy, Snoring, Body | ||||
| Position, Chest Movement | Same | |||
| SW Analysis | ||||
| output | • Respiratory indices | |||
| (pRDI, pAHI,pAHIc) | ||||
| • Sleep stages (REM, | ||||
| light, deep and wake) | ||||
| • Snoring level | ||||
| • Body position | ||||
| discrete states | ||||
| • Heart rate statistics | ||||
| • Oximetry statistics | • Respiratory indices | |||
| (pRDI, pAHI,pAHIc) | ||||
| • Sleep stages (REM, | ||||
| light, deep and wake) | ||||
| • Snoring level | ||||
| • Body position | ||||
| discrete states | ||||
| • Heart rate statistics | ||||
| • Oximetry statistics | • Respiratory indices | |||
| (pRDI, pAHI,pAHIc) | ||||
| • Sleep stages (REM, | ||||
| light, deep and wake) | ||||
| • Snoring level | ||||
| • Body position | ||||
| discrete states | ||||
| • Heart rate statistics | ||||
| • Oximetry statistics | Same | |||
| Arrhythmia flagging output: | ||||
| • Suspected Atrial | ||||
| Fibrillation (AFib): | ||||
| ○ Total duration in | ||||
| sleep | ||||
| ○ Longest event | ||||
| duration | ||||
| • Premature beats: | ||||
| ○ Events per | ||||
| minute | Arrhythmia flagging output: | |||
| • Suspected Atrial | ||||
| Fibrillation (AFib): | ||||
| ○ Total duration in | ||||
| sleep | ||||
| ○ Longest event | ||||
| duration | ||||
| • Premature beats: | ||||
| ○ Events per | ||||
| minute | No Arrhythmia output | Same as WP300 | ||
| Input uPAT Probe | Itamar proprietary probe | |||
| only | Itamar proprietary probe | |||
| only | Itamar proprietary probe | |||
| only | Same | |||
| HW Components | • uPAT finger probe | |||
| • Actigraph | ||||
| • Controller | ||||
| • Chest sensor (optional) | • uPAT finger probe | |||
| • Actigraph | ||||
| • Controller | ||||
| • Chest sensor (optional) | ||||
| • External Tamper-Proof | ||||
| Bracelet (optional) | • uPAT finger probe | |||
| • Actigraph | ||||
| • Controller | ||||
| • Chest sensor | Same except | |||
| optional Tamper | ||||
| Proof Bracelet not | ||||
| available in WP1, | ||||
| and chest sensor | ||||
| was not optional in | ||||
| predicate WP1. | ||||
| Power Supply | One OTS 1.5V Alkaline | |||
| AAA battery | One OTS 1.5V Alkaline | |||
| AAA battery | ||||
| OR | ||||
| One rechargeable AAA | ||||
| 1.2V Nickel-metal hydride | ||||
| (NiMH) battery | One OTS 1.5V Alkaline | |||
| AAA battery | Same as WP1, | |||
| single use battery | ||||
| only | ||||
| Sensors | ||||
| Placement | Wrist, finger and chest | |||
| (optional) | Wrist, finger and chest | |||
| (optional) | Wrist, finger and chest | Same, except for | ||
| chest not being | ||||
| optional in | ||||
| predicate WP1 | ||||
| Intended user of | ||||
| the Arrhythmia | ||||
| output | Physician | Physician | No Arrhythmia output | Same as WP300 |
| Arrhythmia | ||||
| Monitoring period | During prescribed | |||
| sleep study | During prescribed | |||
| sleep study | No Arrhythmia output | Same as WP300 | ||
| Arrhythmia | ||||
| output | ||||
| technological | ||||
| characteristic | PPG | PPG | No Arrhythmia output | Same as WP300 |
7
8
Conclusions
The subject WP1 has the same technological characteristics and principles of operation as its predicates and the new SW arrhythmia feature does not raise any new questions of safety or efficacy. Substantial equivalence of the subject device has been proven towards the predicate, and the differences in HW between the WP300 (from which the new SW feature for Arrhythmia detection was cleared) and the subject WP1 do not raise new questions of safety or effectiveness. Thus, the subject WP1 is substantially equivalent. Based on the above Itamar Medical Ltd. concludes that the WP1 is substantially equivalent to its predicate and does not raise any new or different concerns about safety or effectiveness.